RxDoctor Payments Data

William Artrip, MD

Obstetrics & Gynecology · Ronceverte, WVNPI 1407234867

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (52.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 66.5% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $4,064, more than ten times the $155 reported in 2019.

$6,006in general payments, 2019–2025

Across 117 payments — averaging $51.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • AbbVie$378
  • Pfizer$298
  • Astellas Pharma US Inc$200
  • Amgen$197
  • Bayer$150
  • plus $787 from 15 others

What the payments were for

  • Travel & lodging$98016%
  • Food & beverage$1,90532%
  • Education$3,12252%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,006 in reported general payments places this provider in the 85th percentile of 172 obstetrics & gynecology providers in West Virginia.

See all obstetrics & gynecology providers in West Virginia

Medicare billing

Part B allowed, 2024
$3,967
Medicare patients
34
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol52$2,077
Estradiol (Twice Weekly)Estradiol12$1,111
Medroxyprogesterone Acetate12$425
Oxybutynin Chloride ErOxybutynin Chloride14$133

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Ronceverte

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →